Curaleaf Holdings Files 8-K: Seeks Halt to Aurora Share Issuance

What Happened
Curaleaf Holdings, Inc. announced on September 14, 2026 that it submitted an application to the Alberta Securities Commission asking for an order to halt Aurora Cannabis Inc.'s share issuance program while Curaleaf's pending offer for Aurora remains outstanding. The announcement was made via a press release attached to the Form 8-K as Exhibit 99.1. The Form 8-K notes the press release is furnished (not “filed”) under SEC rules and therefore is not subject to Section 18 liability.

Key Details

• Date filed: September 14, 2026.
• Action: Curaleaf applied to the Alberta Securities Commission to halt Aurora’s share issuance program.
• Context: The requested halt is requested to apply during Curaleaf’s pending offer for Aurora.
• Filing note: Press release is attached as Exhibit 99.1 and is furnished under General Instruction B.2 (not “filed” for Section 18 liability).
• Signature: The report was signed by Peter Clateman, Chief Legal Officer of Curaleaf.

Why It Matters
This is a regulatory step tied directly to Curaleaf’s pending offer and aims to prevent potential dilution or changes to Aurora’s capital structure while the offer is active. Investors in Curaleaf and Aurora should view this as an important procedural move in the offer process; it may affect the timeline and competitive dynamics of the transaction but the filing itself contains no financial terms or outcomes.